SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : InvestRight - Short Term Trading St
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jeffrey L. Henken who wrote (140)9/13/1998 10:24:00 PM
From: rebecca  Read Replies (3) of 939
 
Well this upcoming week certainly continues to present itself as "Tums for the Long Term" .

Regarding biotechs, it is certainly clear that a rally has began in the 2nd and 3rd tier biotechs such as cnto, bgen , sepr and medi.

EXIT and RGEN may appear promising. Yet, they are years away from data with significant results or FDA approval. Such thinly traded issues with no analyst coverage can be diced far below their 52 week lows with the current flight to safety mentality. Personally I feel these type of stocks offer too high of a risk reward ratio for this environment.
I think there is still leverage and safer plays in the third tier companies mentioned above.
Jeff, any technical assessements on any of these issues??

Rebecca
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News